These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16773073)

  • 21. Postoperative radiation for lung cancer metastatic to the brain.
    Armstrong JG; Wronski M; Galicich J; Arbit E; Leibel SA; Burt M
    J Clin Oncol; 1994 Nov; 12(11):2340-4. PubMed ID: 7964950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allosteric modification of oxygen delivery by hemoglobin.
    Wahr JA; Gerber M; Venitz J; Baliga N
    Anesth Analg; 2001 Mar; 92(3):615-20. PubMed ID: 11226087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial.
    Yang JJ; Zhou C; Huang Y; Feng J; Lu S; Song Y; Huang C; Wu G; Zhang L; Cheng Y; Hu C; Chen G; Zhang L; Liu X; Yan HH; Tan FL; Zhong W; Wu YL
    Lancet Respir Med; 2017 Sep; 5(9):707-716. PubMed ID: 28734822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study.
    Chabot P; Hsia TC; Ryu JS; Gorbunova V; Belda-Iniesta C; Ball D; Kio E; Mehta M; Papp K; Qin Q; Qian J; Holen KD; Giranda V; Suh JH
    J Neurooncol; 2017 Jan; 131(1):105-115. PubMed ID: 27655223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of canine myocardial high-energy phosphates during low-flow ischemia with modification of hemoglobin-oxygen affinity.
    Weiss RG; Mejia MA; Kass DA; DiPaula AF; Becker LC; Gerstenblith G; Chacko VP
    J Clin Invest; 1999 Mar; 103(5):739-46. PubMed ID: 10074492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation study.
    Zhou L; He J; Xiong W; Liu Y; Xiang J; Yu Q; Liang M; Zhou X; Ding Z; Huang M; Ren L; Zhu J; Li L; Hou M; Ding L; Tan F; Lu Y
    Lung Cancer; 2016 Jun; 96():93-100. PubMed ID: 27133757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New hope for old drug in patients with brain metastases.
    Cannell E
    Lancet Oncol; 2006 Feb; 7(2):106. PubMed ID: 16468181
    [No Abstract]   [Full Text] [Related]  

  • 29. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.
    Franciosi V; Cocconi G; Michiara M; Di Costanzo F; Fosser V; Tonato M; Carlini P; Boni C; Di Sarra S
    Cancer; 1999 Apr; 85(7):1599-605. PubMed ID: 10193952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of bendamustine with concurrent whole brain radiation therapy in patients with brain metastases from solid tumors.
    Pan E; Yu D; Zhao X; Neuger A; Smith P; Chinnaiyan P; Yu HH
    J Neurooncol; 2014 Sep; 119(2):413-20. PubMed ID: 24965340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recursive Partitioning Analysis Groups II-III brain metastases of non-small cell lung cancer: a phase II randomized study comparing two concurrent chemoradiotherapy regimens.
    Quantin X; Bozonnat MC; Pujol JL
    J Thorac Oncol; 2010 Jun; 5(6):846-51. PubMed ID: 20421817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing P(50) does not improve DO(2CRIT) or systemic VO(2) in severe anemia.
    Eichelbrönner O; D'Almeida M; Sielenkämper A; Sibbald WJ; Chin-Yee IH
    Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H92-101. PubMed ID: 12063279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
    Addeo R; De Rosa C; Faiola V; Leo L; Cennamo G; Montella L; Guarrasi R; Vincenzi B; Caraglia M; Del Prete S
    Cancer; 2008 Nov; 113(9):2524-31. PubMed ID: 18798231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy plus carboplatin and teniposide in patients with brain metastases from non small cell lung cancer.
    Pronzato P; Bruna F; Neri E; Roveri D; Trabucchi A; Vanoli M; Vigani A; Vaira F; Losardo P; Bertelli G
    Anticancer Res; 1995; 15(2):517-9. PubMed ID: 7539236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
    Rades D; Schild SE; Lohynska R; Veninga T; Stalpers LJ; Dunst J
    Cancer; 2007 Sep; 110(5):1077-82. PubMed ID: 17614294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Association of radiation- and fotemustine-therapy in the management of brain metastases from non-small-cell cancers of the lung].
    Pignon T; Astoul P; Ruggieri S; Vialette JP; Orabona P; Muracciole X; Boutin C; Juin P
    Bull Cancer Radiother; 1994; 81(1):49-51. PubMed ID: 7893524
    [No Abstract]   [Full Text] [Related]  

  • 38. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases.
    Carde P; Timmerman R; Mehta MP; Koprowski CD; Ford J; Tishler RB; Miles D; Miller RA; Renschler MF
    J Clin Oncol; 2001 Apr; 19(7):2074-83. PubMed ID: 11283141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efaproxiral: should we hold our breath?
    Sneed PK
    J Clin Oncol; 2006 Jan; 24(1):13-5. PubMed ID: 16314614
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.